'Buy now, pay later' is surging in popularity, but you could regret it

Österreich Nachrichten Nachrichten

'Buy now, pay later' is surging in popularity, but you could regret it
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 kgun9
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

Many shoppers are using 'buy now, pay later' plans to finance their holiday shopping, but there could be some risks and downsides to doing that.

"Buy now, pay later" plans are surging in popularity this holiday season, with cash-strapped consumers no longer receiving stimulus checks and expanded child tax credits to help with the bills.Paige Allen is among those trying to finish up their holiday shopping right now.

"It helps around Christmas time," she said,"because it gives you time to figure out what you want to buy and pay for it after the holidays." The week of Cyber Monday, for example,"buy now pay later" orders were up 85 percent compared to the previous week, it found.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

kgun9 /  🏆 584. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Feds warn of dangers of buy now, pay laterFeds warn of dangers of buy now, pay laterBuy now, pay later companies are giving people extra credit, but the government warns there are some downsides — fees, charges and data harvesting.
Weiterlesen »

Amgen Agrees to Deal to Buy Horizon TherapeuticsAmgen Agrees to Deal to Buy Horizon TherapeuticsThe U.S. biotech company agreed to buy drugmaker Horizon Therapeutics in a deal valued at $27.8 billion, marking the largest healthcare merger of the year.
Weiterlesen »

Amgen to buy Horizon Therapeutics in $26.4B dealAmgen to buy Horizon Therapeutics in $26.4B dealAmgen is spending more than $26 billion to dive deeper into rare disease treatments with the acquisition of drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a treatment for thyroid eye disease that generated more than $1 billion in its first full year on the market.
Weiterlesen »

Amgen to buy Horizon Therapeutics in $26.4 billion dealAmgen to buy Horizon Therapeutics in $26.4 billion dealAmgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare autoimmune diseases, in a deal valued at $26.4 billion.
Weiterlesen »

Bitcoin Group Agrees to Buy German Bank Bankhaus von der Heydt for $15MBitcoin Group Agrees to Buy German Bank Bankhaus von der Heydt for $15MBitcoin Group agrees to buy one of the world's oldest banks for $15 million. By sheldonreback
Weiterlesen »

The best women's pyjamas to buy now for winterThe best women's pyjamas to buy now for winterScamp & Dude's bold printed pyjamas will add an instant pop of colour to dark winter evenings. We're in love with the brand's signature pink with red leopard and lightning bolt print.
Weiterlesen »



Render Time: 2025-03-01 05:01:05